Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Mulberg

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|September 18, 2012
Drug development: The use of unlicensed/off-label medicines in pediatricsYuichiro Yamashiro, Jennifer Martin, Madlen Gazarian, et al.
Journal of Patient-Reported Outcomes|October 9, 2020
Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severityMelodi Harfouche, Priya S Kishnani, Eva Krusinska, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 29, 2014
Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokineticsHaihao Sun, Richard Vesely, Robert M Nelson, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 15, 2013
Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trialsHaihao Sun, Jessica J Lee, Elektra J Papadopoulos, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 31, 2004
Deficits in size-adjusted bone mass in children with Alagille syndromeIrene E Olsen, Richard F Ittenbach, Alisha J Rovner, et al.
Gastroenterology|July 27, 2016
Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics WorkshopDaniel Leffler, Sonia S Kupfer, Benjamin Lebwohl, et al.
Orphanet Journal of Rare Diseases|February 10, 2019
Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholdersAndrew E Mulberg, Christina Bucci-Rechtweg, Joseph Giuliano, et al.
Journal of Clinical Pharmacology|April 5, 2016
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug DevelopmentYeruk Mulugeta, Jeffrey S Barrett, Robert Nelson, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 23, 2011
Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MTEls Van de Vijver, Kristine Desager, Andrew E Mulberg, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Gastroenterology and Nutrition|September 18, 2012
Drug development: The use of unlicensed/off-label medicines in pediatricsYuichiro Yamashiro, Jennifer Martin, Madlen Gazarian, et al.
Journal of Patient-Reported Outcomes|October 9, 2020
Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severityMelodi Harfouche, Priya S Kishnani, Eva Krusinska, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 29, 2014
Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokineticsHaihao Sun, Richard Vesely, Robert M Nelson, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 15, 2013
Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trialsHaihao Sun, Jessica J Lee, Elektra J Papadopoulos, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 31, 2004
Deficits in size-adjusted bone mass in children with Alagille syndromeIrene E Olsen, Richard F Ittenbach, Alisha J Rovner, et al.
Gastroenterology|July 27, 2016
Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics WorkshopDaniel Leffler, Sonia S Kupfer, Benjamin Lebwohl, et al.
Orphanet Journal of Rare Diseases|February 10, 2019
Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholdersAndrew E Mulberg, Christina Bucci-Rechtweg, Joseph Giuliano, et al.
Journal of Clinical Pharmacology|April 5, 2016
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug DevelopmentYeruk Mulugeta, Jeffrey S Barrett, Robert Nelson, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 23, 2011
Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MTEls Van de Vijver, Kristine Desager, Andrew E Mulberg, et al.
Pageof 5